NO954892L - Heterosyklisk kjemi - Google Patents

Heterosyklisk kjemi

Info

Publication number
NO954892L
NO954892L NO954892A NO954892A NO954892L NO 954892 L NO954892 L NO 954892L NO 954892 A NO954892 A NO 954892A NO 954892 A NO954892 A NO 954892A NO 954892 L NO954892 L NO 954892L
Authority
NO
Norway
Prior art keywords
heterocyclic chemistry
hydrogentartrate
thiadiazol
methylpyridine
hexyloxy
Prior art date
Application number
NO954892A
Other languages
English (en)
Other versions
NO954892D0 (no
NO305560B1 (no
Inventor
Linda Marie Osborne
Lisa Ann Shipley
Svend Treppendahl
Torben Guldager Petersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO954892D0 publication Critical patent/NO954892D0/no
Publication of NO954892L publication Critical patent/NO954892L/no
Publication of NO305560B1 publication Critical patent/NO305560B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO954892A 1993-06-04 1995-12-01 Krystallinsk 3-(4-heksyloksy-1,2,5-tiadiazol-3-yl)-1,2,5,6-tetrahydro-1-metylpyridin-(+)-L-hydrogentartrat, farmas°ytiske preparater som omfatter forbindelsen, samt anvendelse av forbindelsen til fremstilling av et medikament NO305560B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7257293A 1993-06-04 1993-06-04
PCT/DK1994/000205 WO1994029303A1 (en) 1993-06-04 1994-05-26 Heterocyclic chemistry

Publications (3)

Publication Number Publication Date
NO954892D0 NO954892D0 (no) 1995-12-01
NO954892L true NO954892L (no) 1995-12-01
NO305560B1 NO305560B1 (no) 1999-06-21

Family

ID=22108479

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954892A NO305560B1 (no) 1993-06-04 1995-12-01 Krystallinsk 3-(4-heksyloksy-1,2,5-tiadiazol-3-yl)-1,2,5,6-tetrahydro-1-metylpyridin-(+)-L-hydrogentartrat, farmas°ytiske preparater som omfatter forbindelsen, samt anvendelse av forbindelsen til fremstilling av et medikament

Country Status (22)

Country Link
US (1) US5834495A (no)
EP (1) EP0703915B1 (no)
JP (1) JP3190679B2 (no)
KR (1) KR100339115B1 (no)
CN (1) CN1064681C (no)
AT (1) ATE196631T1 (no)
AU (1) AU698673B2 (no)
CA (1) CA2164296C (no)
CZ (1) CZ290550B6 (no)
DE (1) DE69426021T2 (no)
DK (1) DK0703915T3 (no)
ES (1) ES2152315T3 (no)
FI (1) FI955829A (no)
GR (1) GR3035033T3 (no)
HU (1) HUT75038A (no)
IL (1) IL109866A (no)
NO (1) NO305560B1 (no)
NZ (2) NZ267062A (no)
PT (1) PT703915E (no)
SK (1) SK281980B6 (no)
WO (1) WO1994029303A1 (no)
ZA (1) ZA943904B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0821956A1 (en) * 1996-08-01 1998-02-04 Eli Lilly And Company Method for treating disruptive behavior disorders
US6043258A (en) * 1996-08-01 2000-03-28 Eli Lilly And Company Method for treating disruptive behavior disorders with xanomeline
EP0821954A1 (en) * 1996-08-01 1998-02-04 Eli Lilly And Company Method for treating mental retardation
US6090829A (en) * 1996-08-01 2000-07-18 Eli Lilly And Company Method for treating excessive aggression
US6117890A (en) * 1996-08-01 2000-09-12 Eli Lilly And Company Method for treating bipolar disorder
US6034108A (en) * 1997-07-28 2000-03-07 Eli Lilly And Company Method for treating mental retardation
EP3265128A4 (en) 2015-03-06 2018-09-12 Chase Pharmaceuticals Corporation Oxybutynin transdermal therapeutic system muscarinic agonist combination

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264444A (en) * 1989-02-22 1993-11-23 Novo Nordisk A/S Piperidine compounds and use
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5260311A (en) * 1989-02-22 1993-11-09 Novo Nordisk A/S Piperidine compounds and their use

Also Published As

Publication number Publication date
DE69426021T2 (de) 2001-05-17
SK281980B6 (sk) 2001-09-11
CN1064681C (zh) 2001-04-18
IL109866A (en) 2000-06-01
GR3035033T3 (en) 2001-03-30
ES2152315T3 (es) 2001-02-01
CA2164296A1 (en) 1994-12-22
FI955829A0 (fi) 1995-12-04
CZ290550B6 (cs) 2002-08-14
SK152095A3 (en) 1996-10-02
KR960702835A (ko) 1996-05-23
NZ336733A (en) 2001-02-23
NO954892D0 (no) 1995-12-01
ZA943904B (en) 1995-12-04
JP3190679B2 (ja) 2001-07-23
JPH08511008A (ja) 1996-11-19
CA2164296C (en) 2007-01-23
DK0703915T3 (da) 2001-01-22
US5834495A (en) 1998-11-10
FI955829A (fi) 1995-12-04
EP0703915A1 (en) 1996-04-03
AU698673B2 (en) 1998-11-05
AU6924294A (en) 1995-01-03
ATE196631T1 (de) 2000-10-15
IL109866A0 (en) 1994-10-07
CZ321095A3 (en) 1996-09-11
HUT75038A (en) 1997-03-28
DE69426021D1 (de) 2000-11-02
HU9503453D0 (en) 1996-01-29
KR100339115B1 (ko) 2002-11-07
NZ267062A (en) 1999-09-29
NO305560B1 (no) 1999-06-21
EP0703915B1 (en) 2000-09-27
CN1128999A (zh) 1996-08-14
PT703915E (pt) 2001-03-30
WO1994029303A1 (en) 1994-12-22

Similar Documents

Publication Publication Date Title
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
NO893304D0 (no) Heterocykliske forbindelser.
DE69005858D1 (de) Heterocyclische Verbindungen.
NL300035I2 (nl) Gesubstitueerde thiazolidinedionderivaten.
GB9514473D0 (en) Chemical compounds
MX9700696A (es) Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
DE69105462D1 (de) Desinfizierende Zusammensetzung.
TR28098A (tr) 1,2,4-okzadiazol türevleri.
FI952682A (fi) Insektisidisiä 5-substituoituja 2,4-diamiinipyrimidiinijohdannaisia
FI941776A0 (fi) Menetelmä 1,2,4-tiadiatsolien valmistamiseksi
FI962976A (fi) Viherkaihin hoitoon tarkoitettuja koostumuksia, jotka sisältävät beta-salpaajaa
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
MY105128A (en) Bu-3608 derivatives.
NO954892D0 (no) Heterosyklisk kjemi
DE59104765D1 (de) Substituierte 5-Alkoxy-1,2,4-triazol-3-(thi)one.
DE69406836D1 (de) Teilweise als Fungizide verwendbare 3,4-Dioxy-1,2,5-thiadiazole
EP0038003A3 (en) Antidepressant pyrrolylpiperidines
ATE68486T1 (de) 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl - 1h-imidazol.
BR9105402A (pt) Compostos 2,6-alcoxifenil-alquilcetonas e composicoes herbicidas contendo os mesmos
DE69019801D1 (de) Heterocyclische Verbindungen.
DE68910907D1 (de) Fungizide Zusammensetzungen.
NO932258D0 (no) Heterocykliske, skadedyrdrepende forbindelser
DE59005786D1 (de) Heterocyclische Verbindungen.
SU1432991A1 (ru) 4-Метил-5-(4-метилфениламино)-1,2,3-триазол, обладающий противовоспалительной активностью
FI913161A0 (fi) Foerfarande foer framstaellning av n-(3',4'-dimetoxikinnamoyl) antranilsyra.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2003